Michael C. Byrns

1.4k total citations
16 papers, 1.2k citations indexed

About

Michael C. Byrns is a scholar working on Cell Biology, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael C. Byrns has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cell Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael C. Byrns's work include Aldose Reductase and Taurine (10 papers), Hormonal and reproductive studies (6 papers) and Prenatal Substance Exposure Effects (5 papers). Michael C. Byrns is often cited by papers focused on Aldose Reductase and Taurine (10 papers), Hormonal and reproductive studies (6 papers) and Prenatal Substance Exposure Effects (5 papers). Michael C. Byrns collaborates with scholars based in United States. Michael C. Byrns's co-authors include T.M. Penning, Yi Jin, Lisa A. Peterson, Stephan Steckelbroeck, Choua C. Vu, Adegoke O. Adeniji, Ling Duan, Ian A. Blair, Jeffrey D. Winkler and Seon Hwa Lee and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Michael C. Byrns

16 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael C. Byrns United States 16 495 386 317 210 201 16 1.2k
G Salen United States 29 96 0.2× 1.2k 3.1× 354 1.1× 39 0.2× 192 1.0× 77 2.6k
Gary H. Rasmusson United States 24 236 0.5× 808 2.1× 896 2.8× 321 1.5× 46 0.2× 45 1.9k
Rock Breton Canada 18 274 0.6× 530 1.4× 448 1.4× 86 0.4× 26 0.1× 30 1.1k
Joseph Jarabak United States 23 214 0.4× 584 1.5× 265 0.8× 26 0.1× 55 0.3× 46 1.4k
Mizuho Une Japan 22 99 0.2× 542 1.4× 100 0.3× 60 0.3× 40 0.2× 86 1.5k
Jesús Sánchez‐Yagüe Spain 20 64 0.1× 493 1.3× 98 0.3× 81 0.4× 96 0.5× 54 1.1k
T. Nagasaki Japan 11 58 0.1× 502 1.3× 209 0.7× 62 0.3× 81 0.4× 28 1.3k
Arun K. Agrawal United States 20 33 0.1× 314 0.8× 445 1.4× 100 0.5× 70 0.3× 37 1.4k
Alessandro Bolli Italy 19 226 0.5× 524 1.4× 53 0.2× 18 0.1× 69 0.3× 29 987
Tianzhu Zang United States 18 146 0.3× 498 1.3× 76 0.2× 87 0.4× 22 0.1× 26 841

Countries citing papers authored by Michael C. Byrns

Since Specialization
Citations

This map shows the geographic impact of Michael C. Byrns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Byrns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Byrns more than expected).

Fields of papers citing papers by Michael C. Byrns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Byrns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Byrns. The network helps show where Michael C. Byrns may publish in the future.

Co-authorship network of co-authors of Michael C. Byrns

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Byrns. A scholar is included among the top collaborators of Michael C. Byrns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Byrns. Michael C. Byrns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tamae, Daniel, Michael C. Byrns, Brett T. Marck, et al.. (2013). Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum. The Journal of Steroid Biochemistry and Molecular Biology. 138. 281–289. 42 indexed citations
2.
Byrns, Michael C.. (2013). Regulation of progesterone signaling during pregnancy: Implications for the use of progestins for the prevention of preterm birth. The Journal of Steroid Biochemistry and Molecular Biology. 139. 173–181. 42 indexed citations
3.
Liedtke, Andy J., Adegoke O. Adeniji, Mo Chen, et al.. (2013). Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer. Journal of Medicinal Chemistry. 56(6). 2429–2446. 87 indexed citations
4.
Byrns, Michael C., Rebekka Mindnich, Ling Duan, & T.M. Penning. (2012). Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride. The Journal of Steroid Biochemistry and Molecular Biology. 130(1-2). 7–15. 50 indexed citations
5.
Byrns, Michael C.. (2012). Role of Aldo–Keto Reductase Enzymes in Mediating the Timing of Parturition. Frontiers in Pharmacology. 2. 92–92. 20 indexed citations
6.
Adeniji, Adegoke O., Michael C. Byrns, Yi Jin, et al.. (2012). Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based onN-Phenyl-Aminobenzoates and Their Structure–Activity Relationships. Journal of Medicinal Chemistry. 55(5). 2311–2323. 98 indexed citations
7.
Adeniji, Adegoke O., et al.. (2011). Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3). Bioorganic & Medicinal Chemistry Letters. 21(5). 1464–1468. 44 indexed citations
8.
Byrns, Michael C., Yi Jin, & T.M. Penning. (2010). Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insights. The Journal of Steroid Biochemistry and Molecular Biology. 125(1-2). 95–104. 112 indexed citations
9.
Penning, T.M. & Michael C. Byrns. (2009). Steroid Hormone Transforming Aldo‐Keto Reductases and Cancer. Annals of the New York Academy of Sciences. 1155(1). 33–42. 145 indexed citations
10.
Byrns, Michael C., Ling Duan, Seon Hwa Lee, Ian A. Blair, & T.M. Penning. (2009). Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 118(3). 177–187. 99 indexed citations
11.
Byrns, Michael C. & T.M. Penning. (2008). Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chemico-Biological Interactions. 178(1-3). 221–227. 66 indexed citations
12.
13.
Vu, Choua C., et al.. (2006). Formation of 1,4-Dioxo-2-butene-Derived Adducts of 2‘-Deoxyadenosine and 2‘-Deoxycytidine in Oxidized DNA. Chemical Research in Toxicology. 19(8). 982–985. 15 indexed citations
14.
Byrns, Michael C., Choua C. Vu, Jonathan W. Neidigh, et al.. (2006). Detection of DNA Adducts Derived from the Reactive Metabolite of Furan, cis-2-Butene-1,4-dial. Chemical Research in Toxicology. 19(3). 414–420. 77 indexed citations
15.
Byrns, Michael C., Choua C. Vu, & Lisa A. Peterson. (2004). The Formation of Substituted 1,N6-Etheno-2‘-deoxyadenosine and 1,N2-Etheno-2‘-deoxyguanosine Adducts by cis-2-Butene-1,4-dial, a Reactive Metabolite of Furan. Chemical Research in Toxicology. 17(12). 1607–1613. 55 indexed citations
16.
Byrns, Michael C., et al.. (2002). Characterization of Nucleoside Adducts of cis-2-Butene-1,4-dial, a Reactive Metabolite of Furan. Chemical Research in Toxicology. 15(3). 373–379. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Salen Breakdown of academic impact, for papers by Gary H. Rasmusson Breakdown of academic impact, for papers by Rock Breton Breakdown of academic impact, for papers by Joseph Jarabak Breakdown of academic impact, for papers by Mizuho Une Breakdown of academic impact, for papers by Jesús Sánchez‐Yagüe Breakdown of academic impact, for papers by T. Nagasaki Breakdown of academic impact, for papers by Arun K. Agrawal Breakdown of academic impact, for papers by Alessandro Bolli Breakdown of academic impact, for papers by Tianzhu Zang
Rankless by CCL
2026